Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Mol Endocrinol ; 7(1): 23-36, 1993 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8446105

RESUMEN

The location and sequence of androgen responsive elements (AREs) in the 5'-flanking DNA of the androgen-regulated rat probasin (PB) gene were determined. The DNA- and steroid-binding domains of the rat androgen receptor [glutathione-S-transferase (GST)-AR1] and the DNA-binding domain and hinge region alone (GST-AR2) were expressed in Escherichia coli as isopropyl-B-D-thioglactopyranoside-induced fusion proteins with GST and purified using glutathione affinity chromatography. Band shift assays indicated that the AR1 peptide was at least five times more effective than AR2 in binding to PB 5'-flanking DNA (-426 to +28), although both gave qualitatively similar patterns and were displaced by anti-AR antibodies. DNase I footprinting experiments revealed two putative AREs: one between positions -236 and -223 (ARE-1) and the other between -140 and -117 (ARE-2). Hormonal regulation of PB was determined by cotransfecting reporter constructions containing the PB 5'-flanking region (-426 to +28) linked to the bacterial chloramphenicol acetyl transferase (CAT) gene with androgen, glucocorticoid, or progesterone receptor expression vectors into human prostatic carcinoma cells (PC-3). PB-CAT gene expression was more effectively induced by androgens than by glucocorticoids or progestins. Both 5'- and 3'-deletion mapping of the PB 5'-flanking DNA revealed that ARE-1 and ARE-2 were required for androgen regulation. A single base mutation in either ARE resulted in a more than 95% loss of androgen induction of CAT. In comparable transfection experiments, the PB hormone-responsive elements showed a greater induction by androgens than did mouse mammary tumor virus or tyrosine aminotransferase elements. Thus, the preferential androgen regulation of the PB gene involves the participation of two different cis-acting DNA elements that bind AR.


Asunto(s)
Proteína de Unión a Andrógenos/genética , Andrógenos/farmacología , Proteínas de Unión al ADN/metabolismo , Receptores Androgénicos/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos , Factores de Transcripción/metabolismo , Transcripción Genética/efectos de los fármacos , Secuencia de Aminoácidos , Proteína de Unión a Andrógenos/biosíntesis , Animales , Secuencia de Bases , Línea Celular , Secuencia de Consenso , Proteínas de Unión al ADN/genética , Regulación de la Expresión Génica/efectos de los fármacos , Genes , Genes Sintéticos , Células HeLa , Humanos , Isopropil Tiogalactósido/farmacología , Datos de Secuencia Molecular , Ratas , Receptores Androgénicos/genética , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/metabolismo , Receptores de Progesterona/genética , Receptores de Progesterona/metabolismo , Homología de Secuencia de Ácido Nucleico , Factores de Transcripción/genética
6.
Fresenius J Anal Chem ; 370(7): 838-42, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11569861

RESUMEN

The National Institute of Standards and Technology (NIST) has had a major quality-assurance role in the federal effort to reduce lead poisoning of children in the United States through its mission of ensuring the accuracy of chemical measurements. NIST certifies reference materials (standard reference materials--SRMs) that are used to benchmark measurements by secondary and field methods of analysis--to ensure that decisions of great health and economic impact are soundly based on good measurement science. Over the past 10 years, in cooperation with the US Environmental Protection Agency (EPA), US Department of Housing and Urban Development (HUD), and the United States Geological Survey (USGS), NIST has prepared and certified SRMs for lead content in soil, indoor dust, and paint. The role of these materials in meeting regulatory and abatement needs is described and their certified values are summarized.


Asunto(s)
Contaminantes Ambientales/análisis , Plomo/análisis , Estándares de Referencia , Polvo/análisis , Pintura/análisis , Suelo/análisis
7.
Exp Cell Res ; 160(2): 459-70, 1985 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-4043253

RESUMEN

The mouse uterine epithelium under various hormonal regimes is a good system to identify biochemical events associated with cell growth, DNA synthesis and cell division. This is because estradiol-17 beta stimulates the cells to undergo a synchronized wave of DNA synthesis and cell division. Estriol, on the other hand, also stimulates DNA synthesis but because of the rapid loss of this hormone from the tissue some of the cells abort, giving a constant epithelial cell number. Three days of progesterone pretreatment, however, completely suppresses the estradiol-17 beta-induced wave of DNA synthesis and cell proliferation. Using these hormonal treatments we have shown that both estradiol-17 beta and estriol stimulate protein and rRNA synthesis with the concomitant increase of protein and rRNA per mg of DNA. These macromolecules accumulated in direct proportion to the fraction of cell committed to DNA synthesis. Estriol, however, did not sustain the growth responses and at the peak of DNA synthesis both rRNA and protein synthesis had returned to control levels. Progesterone pretreatment, despite inhibiting the proliferative response, failed to inhibit any of the estradiol-17 beta-induced increases in protein and rRNA synthesis. Indeed 12 h after estradiol-17 beta injection the cells had identical protein and rRNA contents, regardless of whether they had been exposed to progesterone or not. The present data therefore suggests that in the uterine epithelium cell growth as defined by protein and rRNA accumulation and DNA synthesis represents two independently regulated pathways.


Asunto(s)
Estradiol/farmacología , Estriol/farmacología , Progesterona/farmacología , Útero/citología , Animales , División Celular/efectos de los fármacos , Replicación del ADN/efectos de los fármacos , Células Epiteliales , Femenino , Ratones , Biosíntesis de Proteínas , ARN Ribosómico/biosíntesis , Ribosomas/análisis , Factores de Tiempo , Útero/efectos de los fármacos
8.
Fresenius J Anal Chem ; 370(2-3): 234-40, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11451243

RESUMEN

The S mass fractions of coal SRMs 2682b, 2684b, and 2685b are certified by direct comparison with coal SRMs 2682a, 2684a, and 2685a, respectively, using high-temperature combustion analysis with infrared (IR) absorption detection. The S mass fractions of the "a" materials used for calibration were previously determined by means of isotope-dilution thermal-ionization mass spectrometry (ID-TIMS). Therefore, the comparisons performed with the combustion-IR absorption method establish direct traceability links to accurate and precise ID-TIMS measurements. The expanded uncertainties associated with the certified S mass fractions are of approximately the same magnitude as would be expected for the ID-TIMS methodology. An important aspect of these certifications is that each "b" material is essentially identical with the corresponding "a" material, because both were produced from the same bulk, homogenized coal. As a test of the efficacy of the new certification approach when calibrant and unknown are not identical, the S mass fraction of coal SRM 2683b has been determined by direct comparison to coal SRM 2683a. These two coals, which have both previously been analyzed with ID-TIMS, are different in terms of S content and other properties. Whereas the S mass fraction for SRM 2683b determined with the new methodology agrees statistically with the ID-TIMS value, there is reason for caution in such cases. In addition to the usefulness of the alternative approach for certification activities within NIST, this approach might also be an excellent way of establishing NIST traceability during the value assignment process for reference materials not issued by NIST. Further research is needed, however, to understand better the scope of applicability.

9.
Antimicrob Agents Chemother ; 3(2): 224-7, 1973 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-4597717

RESUMEN

Two new investigational antimalarial drugs developed by the U.S. Army Malaria Research Program were tested in patients with multi-drug-resistant falciparum malaria from Vietnam. WR 33063, a phenanthrene methanol, cured 13 patients treated in the United States. All of these patients had suffered multiple recrudescences after treatment with standard antimalarial drugs. In addition, 23 of 25 patients with acute attacks of falciparum malaria treated in Vietnam were cured. The rate of clinical response was prompt. WR 30090, a quinoline methanol, similarly cured eight patients with multiple recrudescences in the United States and 23 of 26 patients in Vietnam. Adverse effects associated with the drugs were not seen. These drugs signify a major advance in the chemotherapy of drug-resistant falciparum malaria.


Asunto(s)
Antimaláricos/uso terapéutico , Malaria/tratamiento farmacológico , Fenantrenos/uso terapéutico , Plasmodium falciparum , Quinolinas/uso terapéutico , Butilaminas/uso terapéutico , Humanos , Metanol/uso terapéutico , Metilaminas/uso terapéutico , Vietnam
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA